Get started
Author

Ricardo Antonio Rodriguez Mejia

Observed names: Ricardo A Rodriguez Mejia, Ricardo A. Rodriguez Mejia
ORCID: 0009-0000-9477-280X
Observed ORCID: 0009-0000-9477-280X
OpenAlex ID: A5039667786
Efficacy of beta-blocker therapy in Takotsubo cardiomyopathy: A systematic review and meta-analysis
2025 · Ricardo A. Rodriguez Mejia, Arminder Singh, et al. · International Journal of Cardiology · 13
Clinical Outcomes of Combined TAVR-PCI Versus SAVR-CABG in Patients with Aortic Stenosis and Coronary Artery Disease: A Systematic Review and Meta-Analysis
2026 · Ricardo Antonio Rodriguez Mejia, Mathhar Aldaoud, et al. · Journal of Clinical Medicine
Abstract 4366572: Impact of Type 2 Myocardial Infarction in Diabetic Ketoacidosis: Insights from a National Cohort
2025 · Ifeanyi Momodu, Shubhadarshini Pawar, et al. · Circulation
Abstract 4340646: Efficacy of Beta-Blocker Therapy in Takotsubo Cardiomyopathy: A Systematic Review and Meta-Analysis
2025 · Ricardo Antonio Rodriguez Mejia, Merina Dongol, et al. · Circulation
Abstract 4343216: Guideline-Directed Medical Therapy and Clinical Outcomes in African American Women with Congestive Heart Failure from Low- to Medium-Income Backgrounds at a Safety Net Hospital
2025 · Ricardo Antonio Rodriguez Mejia, Eric Acker, et al. · Circulation
Reply to “efficacy of beta-blocker therapy in Takotsubo cardiomyopathy: Insights from a systematic review and meta-analysis”
2025 · Ricardo A. Rodriguez Mejia, Arminder Singh · International Journal of Cardiology
Impact of Medication Dose Optimization on Heart Failure Outcomes in African-American Female Patients: A Safety-Net Hospital Experience
2025 · Ricardo A Rodriguez Mejia, Eric Acker, et al. · Cureus
PDF
Novel Oral Anticoagulants Versus Antiplatelet Therapy in Post-TAVR Patients: A Single-Center Retrospective Study
2025 · Ricardo A. Rodriguez Mejia, Eric Acker, et al. · Journal of Clinical Medicine
PDF
Works count: 8
Citation count: 13
H-index: 1
I10-index: 1
Year
Topic
Type